key: cord-0304265-5afugdki authors: Waggoner, J.; Vos, M. B.; Tyburski, E. A.; Nguyen, P.-V.; Ingersoll, J. M.; Miller, C.; Sullivan, J.; Griffiths, M.; Stone, C.; Benoit, M.; Benedit, L.; Seitter, B.; Jerris, R.; Levy, J. M.; Kraft, C. S.; Farmer, S.; Foster, A.; Wood, A.; Westbrook, A. L.; Morris, C. R.; Sathian, U. N.; Heetderks, W.; Li, L.; Roth, K.; Barcus, M.; Stenzel, T.; Martin, G. S.; Lam, W. A. title: Adequacy of Self-Collected Anterior Nares Swabs for SARS-CoV-2 Testing by Grade School Children date: 2022-03-09 journal: nan DOI: 10.1101/2022.03.07.22270699 sha: 3d8e6cc248e279de5c0b36bed9111d9259bc8041 doc_id: 304265 cord_uid: 5afugdki Background. The goal of this study was to characterize the ability of school-aged children to self-collect adequate anterior nares (AN) swabs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing. Methods. From July to August 2021, 287 children, age 4-14 years-old, were prospectively enrolled in the Atlanta area. Symptomatic (n=197) and asymptomatic (n=90) children watched a short instructional video before providing a self-collected AN specimen. Health care workers (HCWs) then collected a second specimen, and useability was assessed by the child and HCW. Swabs were tested side-by-side for SARS-CoV-2. RNase P RNA detection was investigated as a measure of specimen adequacy. Results. Among symptomatic children, 87/196 (44.4%) tested positive for SARS-CoV-2 by both self- and HCW-swab. Two children each were positive by self- or HCW-swab; one child had an invalid HCW-swab. Compared to HCW-swabs, self-collected swabs had 97.8% and 98.1% positive and negative percent agreements, respectively, and SARS-CoV-2 Ct values did not differ significantly between groups. Participants [≤]8 years-old were less likely than those >8 to be rated as correctly completing self-collection, but SARS-CoV-2 detection did not differ. Based on RNase P RNA detection, 270/287 children (94.1%) provided adequate self-swabs versus 277/287 (96.5%) HCW-swabs (p=0.24) with no difference when stratified by age. Conclusions. Children, aged 4-14 years-old, can provide adequate AN specimens for SARS-CoV-2 detection when presented with age-appropriate instructional material, consisting of a video and a handout, at a single timepoint. These data support the use of self-collected AN swabs among school-age children for SARS-CoV-2 testing. As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has evolved, testing 46 has become widely available for children and adults who may have coronavirus disease (COVID-19), the disease caused by SARS-CoV-2. However, testing capacity remains insufficient for repeat testing of 48 asymptomatic school children and group settings for children, such as camps and schools, that are less 49 likely to have trained health care workers (HCWs) available for sample collection. Long-standing medical 50 practice has been to have a HCW collect samples for respiratory tract infection testing, which typically 51 involves swabbing in the nose or mouth. Little data exists to suggest that HCW-collection is necessary, 52 and it remains a barrier to expanding testing in locations with large numbers of children and limited 53 access to healthcare personnel. Comparison of parental and nurse nasal swab collection for respiratory 54 tract infection in children has demonstrated that nasal swab samples collected by parents are comparable 55 to nurse-collected samples, 1 however even this has not become routine for younger children. swabs are preferred for self-collection because they are technically less complex. However, the age at 62 which nasal self-swabbing would generally be successful and how much it may affect sensitivity of 63 COVID-19 testing is not known, and tests authorized by the FDA under EUA are not authorized for self-64 swabbing by children <14 years-old. Thus, there is a need to better understand at what age children can 65 self-swab to provide a specimen for testing. This study was a collaboration between Emory University, 66 Children's Healthcare of Atlanta, the Rapid Acceleration of Diagnostics (RADx) initiative of the National 67 Institutes of Health National Institute of Biomedical Imaging and Bioengineering (NIH, NIBIB), and the 68 FDA to generate data to support evidence-based recommendations to schools and other group settings 69 with children regarding utilization of self-swabbing. Because the definition of an adequate sample was 70 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 9, 2022. ; https://doi.org/10.1101/2022.03.07.22270699 doi: medRxiv preprint undefined from our review of the literature, we conducted a multi-part study to answer the following 71 study questions: 1) Are children, after hearing and seeing simple instructions, able to self-collect AN 72 swabs for SARS-CoV-2 testing? 2) In children with suspected COVID-19, is self-swabbing as effective 73 for detecting SARS-CoV-2 as HCW-swabbing? And 3) Can RNase P RNA serve as an indicator of AN 74 swab specimen adequacy during periods of low respiratory virus transmission? 75 76 Methods 77 Ethics statement. All studies were approved by the Emory University IRB and all participants provided 78 consent (and assent, where indicated by age) prior to participating. 79 80 Symptomatic children. A prospective cohort of symptomatic SARS-CoV-2 positive and negative 81 children was recruited into a cross sectional study to compare self-swabbing to HCW-swabbing for 82 SARS-CoV-2 detection. Symptomatic children were recruited based on a daily report generated of all 83 children testing positive by standard of care nasopharyngeal (NP) swab within the Children's Healthcare 84 of Atlanta System in the previous 24 hours. Target enrollment was 10 COVID-positive and 10 COVID-85 negative children in each age group. Parents were called and asked to return to a Drive-Thru testing site 86 set up at the Center for Advanced Pediatrics. Children were excluded if self-swabbing was not feasible 87 due to a medical condition; developmental delay precluded the child from understanding the instructions 88 in the opinion of the parent (or guardian); or the child had a history of nosebleeds in the past 2 weeks. If a 89 SARS-CoV-2-positive child returned for the self-swabbing study ≥48 hours after their most recent 90 positive test, a repeat, standard-of-care NP COVID test was obtained after AN swab collection for the 91 current study. 92 93 Once consented, a video of children teaching and demonstrating how to self-swab was shown, and 94 children were provided with an instructional handout with images on one side and images plus written 95 instructions on the other (Supplemental Material). The child then performed the self-swab followed by the 96 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 9, 2022. ; https://doi.org/10.1101/2022.03.07.22270699 doi: medRxiv preprint a Nylon Flocked Swab (regular size with 30mm breakpoint; Copan Diagnostics, Murrieta, CA) were 98 performed in each naris. Then the swab was given to the HCW, who placed it in a sterile cryovial pre-99 filled with 1mL saline. The same process was repeated by the HCW. The 3 HCWs who conducted all 100 swabbing for this project were highly skilled and experienced pediatric nurses. Following collection, 101 samples were immediately placed on ice and transported to the laboratory by courier at the end of each 102 day. Samples were stored at 4°C for up to 72 hours prior to nucleic acid extraction and testing. If the 103 expected duration of storage exceeded 72 hours, samples were stored at -80°C. 104 105 RNase P RNA detection -Pilot study. The overall study was planned and initiated during the nadir in 106 SARS-CoV-2 transmission that occurred during the spring and early summer of 2021. 2 As such, RNase P 107 RNA detection was evaluated as an investigational measure of specimen adequacy. A retrospective pilot 108 study was conducted to determine if RNase P RNA could be detected in HCW-collected AN samples. days. An outdoor testing tent was set up near the neighborhood clubhouse. Children came with their 121 parents and consent and assent were obtained. A small number of children were recruited by word of 122 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 9, 2022. ; https://doi.org/10.1101/2022.03.07.22270699 doi: medRxiv preprint mouth to target specific ages that were needed to achieve the target enrollment following these 2 days. In 123 addition to the exclusion criteria for symptomatic children, asymptomatic children were also excluded if 124 COVID-19 had been suspected/diagnosed in the past 30 days or if the child had current respiratory 125 symptoms or other COVID-19 symptoms in the past 2 weeks. Children observed the same video and were 126 provided with the same instructional handout prior to self-swabbing, as described above. The research 127 team of nurses and research coordinators followed the same process as described for the symptomatic 128 Norway) according to manufacturer recommendations. Resulting RNA was immediately tested by real-165 time RT-PCR (rRT-PCR) for the nucleocapsid 2 (N2) target and RNase P. The assay was run as duplex 166 test but otherwise performed as described. 6 A specimen was considered to have detectable SARS-CoV-2 167 or RNase P RNA if it yielded a Ct value ≤ 40 for that target in the duplex assay. Samples from 21 168 children with detectable SARS-CoV-2 RNA were also tested in a multiplex rRT-PCR for specific spike 169 mutations associated with variants of concern. This assay was performed, as described, 7,8 using DNase- is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 9, 2022. ; https://doi.org/10.1101/2022.03.07.22270699 doi: medRxiv preprint undetectable SARS-CoV-2 RNA but detectable signal for RNase P. Positive concordant pairs had 175 detectable SARS-CoV-2 RNA. Useability data were evaluated by age and when binned as ≤8 and >8 176 years-old, based on initial review of the results. Descriptive statistics for the study were reported as 177 medians and interquartile ranges for continuous variables and counts with percentages for categorical 178 variables. Shapiro-Wilk tests were used to check normality of continuous data. Two-group comparisons 179 were conducted using students t-tests for normally distributed continuous data. Wilcoxon rank-sum tests 180 were used for non-normal continuous data. Categorical data was compared using chi-squared tests 181 or Fisher's exact tests for expected cell counts <5. Statistical significance was assessed at the 0.05 level. 182 All statistical analyses were conducted using SAS 9.4 (Cary, NC). is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 9, 2022. ; https://doi.org/10.1101/2022.03.07.22270699 doi: medRxiv preprint swabs ( Figure 3C ). Children with lower Ct values in the self-collected swab were more likely to be 201 black/African American and present earlier in the course of illness. No other differences were noted 202 between these groups (Table S1 ). Finally, 4 participants had discordant qualitative SARS-CoV-2 results; 203 all had N2 Ct values > 30.0 from the positive sample ( Figure 2D , Table 2 ). 204 205 Investigational RNase P RNA detection. In the retrospective pilot study, RNase P was detected in AN 206 swabs from all 24 asymptomatic children. RNase P Cts were significantly higher in DNase treated versus 207 untreated eluates (mean Ct 31.6 ± 2.7 vs. 23.8 ± 2.6, respectively; p <0.001, Figure S1A ). RNase P RNA 208 Cts did not differ significantly between samples with and without detectable SARS-CoV-2 RNA or based 209 on the SARS-CoV-2 Ct in positive samples ( Figure S1B and C). Based on the pilot data, 90 asymptomatic 210 children, aged 5-12 years-old, were enrolled in July 2021 (Figure 1) , and all self-and HCW-collected 211 swabs from symptomatic and asymptomatic children were tested with the investigational study protocol. there was no difference in specimen adequacy overall or stratified by age. However, one or both swabs 217 from 19 participants would have been considered inadequate based on RNase P RNA detection alone: 9 218 self-swabs, 9 HCW-swabs, and 1 both swabs ( Figure S2 ). For asymptomatic children, all HCW-collected 219 and 83 self-collected swabs were considered adequate (p=0.01; Table 3, Figure S3A ). RNase P RNA Ct 220 values were similar for children who had adequate self-and HCW-swabs ( Figures S2C and S3B) . A 221 single individual had detectable SARS-CoV-2 RNA, which was detected in both the self-and HCW-222 collected swab. This result was confirmed in the CDC EUA rRT-PCR. Notably, 4 individuals with 223 inadequate self-swabs on the first attempt were re-contacted and were trained again on self-swabbing. All 224 self-swabs from the repeat collection had detectable RNase P RNA. 225 226 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 9, 2022. The COVID-19 pandemic has illuminated the need for increased testing capacity across all age groups. 240 Although SARS-CoV-2 testing capacity has dramatically increased, namely due to new testing 241 technologies receiving EUA and deployed for lab and non-lab settings, many testing schemas involve 242 HCWs for sampling. There have been several tests and collection kits deployed for use in the home which 243 utilize self-collection and collection from children by their parents or guardians, but few options exist for 244 pediatric self-collection. This has made it challenging to test and screen pediatric populations due to the 245 need for trained individuals at the school or group setting to collect samples. One prior study investigated 246 the feasibility of AN swab self-collection by school-aged children based on the rate of observed 247 deviations from a standard collection protocol, but results of molecular testing were not reported. 9 In 248 contrast, the studies presented here characterized the ability of school-aged children to adequately self-249 collect AN samples based on the results of SARS-CoV-2 molecular testing and evaluated the useability of 250 self-collection from both the child and HCW perspective. 251 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 9, 2022. ; https://doi.org/10.1101/2022.03.07.22270699 doi: medRxiv preprint When provided with video and printed instructions, children in all tested age groups were able to 253 adequately self-collect AN samples for the purposes of SARS-CoV-2 testing. There was no significant 254 bias or improvement in performance based on collected demographic variables. These findings support 255 that pediatric self-collection can be used for SARS-CoV-2 testing and could decrease the burden of HCW 256 requirements in existing testing strategies. Additionally, the results support the potential for non-257 traditional testing schemas for children, including self-collection and sample drop off at schools, prior to 258 events, and even testing at home. These results fill an important void and contribute to the scarce data that 259 exists on pediatric involvement in ongoing testing efforts. 260 This study was planned and initiated during a nadir in COVID-19 cases in Georgia. Detection of SARS-262 CoV-2 RNA was the preferred endpoint, but with low rates of infection during the planning phase of the 263 study, additional exploratory outcome measures were considered. As such, RNase P RNA was evaluated 264 as an ancillary measure of specimen adequacy. This required an additional step following nucleic acid 265 extraction to remove genomic DNA, which is also detected in the RNase P assay that is commonly used 266 as a specimen control. 5 RNase P RNA was detectable in the majority of AN swabs, with no significant 267 difference between self-and HCW-collected samples. One or both swabs from 19 symptomatic and 7 268 self-swabs from asymptomatic participants were considered inadequate based on RNase P RNA 269 detection. However, no meaningful difference in SARS-CoV-2 RNA detection using the CDC EUA rRT-270 PCR was detected, which was the primary outcome measure of the study. These data indicate that, 271 although RNase P RNA detection provides a rigorous indicator of specimen adequacy, it may be a more 272 demanding measure than viral RNA detection and overestimate collection failure. 273 There are a few limitations to the work presented. Data comparing SARS-CoV-2 detection in self-versus 275 HCW-collected samples were limited to symptomatic participants, and there was not sufficient statistical 276 power to detect small differences in SARS-CoV-2 detection by year of age. There was only one 277 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 9, 2022. ; https://doi.org/10.1101/2022.03.07.22270699 doi: medRxiv preprint asymptomatic child who tested positive for SARS-CoV-2, which did result in positive results for both 278 self-and HCW-collected samples. Further testing should be done to confirm that self-collection is 279 effective for SARS-CoV-2 testing in an asymptomatic pediatric population. 280 281 Given the similar performance of self-and HCW-collected AN swabs, data from the current study support 282 the development of SARS-CoV-2 testing plans for school aged children that allow for self-collection. 283 Such strategies have the potential to improve testing capacity by decreasing the need for trained staff at 284 collection sites, and future work could evaluate the use of self-collected samples for multiplex respiratory 285 viral testing to reduce outbreaks in this population. 286 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 9, 2022. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 9, 2022. ; https://doi.org/10.1101/2022.03.07.22270699 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 9, 2022. ; https://doi.org/10.1101/2022.03.07.22270699 doi: medRxiv preprint Prospective Study of the Performance of Parent-305 Collected Nasal and Saliva Swab Samples, Compared with Nurse-Collected Swab Samples Interviewing children and adults: The effect of question 310 format on the tendency to speculate Asking the tough questions: a guide to ethical practices in interviewing young 312 children Instructions for Use Triplex Real-Time RT-PCR for Severe Acute 316 Respiratory Syndrome Coronavirus 2 Single-amplicon, multiplex real-time RT-PCR 318 with tiled probes to detect SARS-CoV-2 spike mutations associated with variants of concern SARS-CoV-2 variants in Paraguay: Detection and 321 surveillance with a readily modifiable, multiplex real-time RT Feasibility of Specimen Self-collection in Young 324 Children Undergoing SARS-CoV-2 Surveillance for In-Person Learning The authors thank the participants and their families for participation in this study. We acknowledge the 288 contributions of Children's Healthcare of Atlanta Research Coordinators Misty McGhee, Lauren . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 9, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 9, 2022. ; https://doi.org/10.1101/2022.03.07.22270699 doi: medRxiv preprint CoV-2 RNA was only detectable in the self-collected (n=2) or HCW-collected (n=2) specimen. All 339 displayed results were obtained with the CDC EUA rRT-PCR. 340 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 9, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted March 9, 2022. ; https://doi.org/10.1101/2022.03.07.22270699 doi: medRxiv preprint